AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2017
Sep 18, 2017
32814_dirs_2017-09-18_376900d0-b932-4a05-acec-131d371411ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2017-09-15
Reporting Person: BARKER SAM L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-15 | Common Stock | P | 1000 | $12.50 | Acquired | 25623 | Direct |
More from LEXICON PHARMACEUTICALS, INC.
Report Publication Announcement
2026
May 7
Capital/Financing Update
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3